Skip to main content
. 2022 Feb 3;8:775194. doi: 10.3389/fsurg.2021.775194

Figure 9.

Figure 9

Landscape of CD44+ cells in GBM. (A) All GBM cell types are projected on UMAP reduction. GBM is composed of malignant tumor cells, oligodendrocytes, TAMs, T cells, endothelial cells, and pericytes. (B) Expression level of CD44 among different GBM cell types. Only malignant cells, TAMs and T cells express CD44 in GBM. (C) Expression of CD44 in TAMs is projected on UMAP reduction. (D) Top 20 biological processes of DEGs in CD44+ TAMs compared to CD44- TAMs. (E) CD44+ TAMs express M2-type TAM markers CD163 and CD206. (F) UMAP reduction of all six GBM tumor cellular state cells and stem-like cells. (G) Expression level of CD44 among the six GBM tumor cellular state cells and stem-like cells. Only MES1-like tumor cells express CD44 among different cellular states. (H) Expression of CD44 in tumor cells is projected on UMAP reduction. (I) Top 20 biological processes of DEGs in CD44+ tumor cells compared to CD44- tumor cells. (J) CD44-correlated genes in CD44+ malignant cells. Genes labeled in red are immunosuppressive genes, whose expression level positively correlates with CD44; blue colored genes are immune stimulator genes and their expression negatively relates to CD44. (K) Top 20 biological processes of CD44 positive-related genes in CD44+ malignant cells.